Published in Parasitol Res on March 12, 2003
Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochem J (2005) 1.01
Extracellular heme uptake and the challenges of bacterial cell membranes. Curr Top Membr (2012) 0.83
Novel inhibitor cystine knot peptides from Momordica charantia. PLoS One (2013) 0.78
Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol (1979) 23.90
Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol (1997) 3.66
On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci U S A (1996) 3.29
Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci U S A (1990) 3.01
Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry (1980) 2.53
An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci U S A (1991) 2.36
Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature (1995) 2.30
Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett (1994) 2.15
Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol (1998) 1.86
Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol Microbiol (1999) 1.61
Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Parasitol Today (2000) 1.26
New type of febrifugine analogues, bearing a quinolizidine moiety, show potent antimalarial activity against Plasmodium malaria parasite. J Med Chem (1999) 1.05
Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem (2001) 1.04
Metalloporphyrins inhibit beta-hematin (hemozoin) formation. J Inorg Biochem (2000) 0.88
A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Biochemistry (1999) 0.87
Assay of beta-hematin formation by malaria parasite. J Pharm Biomed Anal (1999) 0.85
Oxidative cleavage of DNA mediated by hybrid metalloporphyrin-ellipticine molecules and functionalized metalloporphyrin precursors. Biochemistry (1990) 0.85
Syntheses and in vitro evaluation of water-soluble "cationic metalloporphyrin-ellipticine" molecules having a high affinity for DNA. J Med Chem (1991) 0.85
Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation. FEBS Lett (1997) 0.83
Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5, 7-pentoxocanes and 1,2,4,5-tetroxanes. J Med Chem (1999) 0.82
[Interaction of chloroquine with ferriprotophorphyrin IX. Nuclear magnetic resonance study]. Biochimie (1983) 0.79
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes. Biochem Pharmacol (1992) 0.79
Host range and molecular phylogenies of the soft rot enterobacterial genera pectobacterium and dickeya. Phytopathology (2007) 1.81
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev (2004) 1.58
Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin. Hepatology (2013) 1.50
Catalytic Asymmetric Synthesis of Antimalarial Alkaloids Febrifugine and Isofebrifugine and Their Biological Activity. J Org Chem (1999) 1.24
Clinical characteristics of imported malaria in Japan: analysis at a referral hospital. Am J Trop Med Hyg (2005) 1.14
In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. J Ethnopharmacol (2003) 1.10
Replication of Neisseria meningitidis within epithelial cells requires TonB-dependent acquisition of host cell iron. Infect Immun (2002) 1.08
Biofilm formation by Neisseria meningitidis. Infect Immun (2004) 1.05
Epidemiology, hypermutation, within-host evolution and the virulence of Neisseria meningitidis. Proc Biol Sci (2003) 1.04
Potent antimalarial febrifugine analogues against the plasmodium malaria parasite. J Med Chem (2002) 1.02
Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite. J Med Chem (2003) 1.01
Histidine pK(a) shifts and changes of tautomeric states induced by the binding of gallium-protoporphyrin IX in the hemophore HasA(SM). Protein Sci (2002) 1.00
Chryseobacterium kwangjuense sp. nov., isolated from pepper (Capsicum annuum L.) root. Int J Syst Evol Microbiol (2013) 0.98
Preparation of quinoline hexose analogs as novel chloroquine-resistant malaria treatments (1). Synthesis of 4-hydroxyquinoline-beta-glucosides. Chem Pharm Bull (Tokyo) (2007) 0.97
Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother (2003) 0.96
Detection of malaria parasites in mosquitoes from the malaria-endemic area of Chakaria, Bangladesh. Biol Pharm Bull (2008) 0.95
Antimalarial activity of lavandulyl flavanones isolated from the roots of Sophora flavescens. Biol Pharm Bull (2004) 0.94
Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol Pharm Bull (2005) 0.93
Development and evaluation of an improved mouse model of meningococcal colonization. Infect Immun (2003) 0.91
Inducible, but not constitutive, resistance of gonococci to hydrophobic agents due to the MtrC-MtrD-MtrE efflux pump requires TonB-ExbB-ExbD proteins. Antimicrob Agents Chemother (2002) 0.91
New neplanocin analogues. 12. Alternative synthesis and antimalarial effect of (6'R)-6'-C-methylneplanocin A, a potent AdoHcy hydrolase inhibitor. J Med Chem (2002) 0.90
Natural transformation and phase variation modulation in Neisseria meningitidis. Mol Microbiol (2004) 0.88
Association of RNase L with a Ras GTPase-activating-like protein IQGAP1 in mediating the apoptosis of a human cancer cell-line. FEBS J (2010) 0.88
Synthesis and notable antimalarial activity of acyclic peroxides, L-(alkyldioxy)-L-(methyldioxy)cyclododecanes. J Med Chem (2002) 0.87
Toxoplasma gondii: a simple high-throughput assay for drug screening in vitro. Exp Parasitol (2008) 0.87
What's special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study. Mov Disord (2014) 0.86
Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity. J Med Chem (2002) 0.85
Synthesis of 2-fluoronoraristeromycin and its inhibitory activity against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase. Bioorg Med Chem Lett (2003) 0.85
Genomic analysis of mefloquine-resistant Plasmodium falciparum. Nucleic Acids Res Suppl (2002) 0.84
Resistance of neisseria meningitidis to the toxic effects of heme iron and other hydrophobic agents requires expression of ght. J Bacteriol (2005) 0.83
IgE binding synthetic peptides of Alt a 1, a major allergen of Alternaria alternata. Peptides (2003) 0.83
Parallel synthesis of antimalarial rhodacyanine dyes by the combination of three components in one pot. J Comb Chem (2003) 0.82
Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106). Nucleic Acids Res Suppl (2002) 0.82
Self-catalyzed site-specific depurination of G residues mediated by cruciform extrusion in closed circular DNA plasmids. J Biol Chem (2011) 0.82
Identification of Neisseria meningitidis genetic loci involved in the modulation of phase variation frequencies. Infect Immun (2004) 0.82
Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine. Cancer Chemother Pharmacol (2008) 0.81
1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo. Int J Oncol (2009) 0.80
Osteomyelitis of the mandible due to Aggregatibacter (Actinobacillus) actinomycetemcomitans. Indian J Pathol Microbiol (2009) 0.80
Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine. FEBS J (2014) 0.79
Genetic analysis of mefloquine-resistant mechanism of Plasmodium falciparum. Nucleic Acids Symp Ser (Oxf) (2004) 0.79
Synthesis and evaluation of beta-carbolinium cations as new antimalarial agents based on pi-delocalized lipophilic cation (DLC) hypothesis. Chem Pharm Bull (Tokyo) (2005) 0.79
Duffy antigen is important for the lethal effect of the lethal strain of Plasmodium yoelii 17XL. Parasitol Res (2004) 0.79
Schistosomicidal and antifecundity effects of oral treatment of synthetic endoperoxide N-89. Parasitol Int (2011) 0.79
Pi-delocalized beta-carbolinium cations as potential antimalarials. Bioorg Med Chem Lett (2004) 0.79
Proteome analysis of new antimalarial endoperoxide against Plasmodium falciparum. Parasitol Res (2007) 0.79
Antimalarial activity of yingzhaosu A analogues. J Med Chem (2002) 0.78
Synthesis of antimalarial yingzhaosu A analogues by the peroxidation of dienes with Co(II)/O2/Et3SiH. J Org Chem (2003) 0.78
Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm Res (2005) 0.78
Antimalarial effect of bis-pyridinium salts, N,N'-hexamethylenebis(4-carbamoyl-1-alkylpyridinium bromide). Bioorg Med Chem Lett (2006) 0.78
Antimalarial activity of herbal extracts used in traditional medicine in Korea. Biol Pharm Bull (2003) 0.78
Transformation of Cinchona alkaloids into 1-N-oxide derivatives by endophytic Xylaria sp isolated from Cinchona pubescens. Chem Pharm Bull (Tokyo) (2003) 0.78
Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251. J Proteome Res (2012) 0.78
Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. Chem Phys Lipids (2009) 0.78
A novel apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis--the possibility of RNase L activated pathway as a target of ECyd. Nucleic Acids Symp Ser (Oxf) (2007) 0.77
Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol. Parasitol Int (2011) 0.77
New semisynthetic quassinoids with in vivo antimalarial activity. J Med Chem (2003) 0.77
Analysis of single nucleotide polymorphisms in uridine/cytidine kinase gene encoding metabolic enzyme of 3'-ethynylcytidine. Nucleic Acids Res Suppl (2002) 0.77
Proteome and transcriptome analysis of cell death induced by 5-fluoro-2'-deoxyuridine. Nucleic Acids Symp Ser (Oxf) (2007) 0.77
Gene expression profiles of necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine. Genomics (2008) 0.77
Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes. J Med Chem (2003) 0.77
Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini. Nucleic Acids Symp Ser (Oxf) (2008) 0.77
An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L. Nucleic Acids Symp Ser (Oxf) (2006) 0.77
Protein expression profiles of necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine in mouse cancer cells. J Proteome Res (2010) 0.76